Drug Shortage Report for LOTEMAX

Last updated on 2018-08-24 History
Report ID 55690
Drug Identification Number 02321114
Brand name LOTEMAX
Common or Proper name LOTEMAX
Company Name BAUSCH & LOMB INC
Market Status MARKETED
Active Ingredient(s) LOTEPREDNOL ETABONATE
Strength(s) 0.5%
Dosage form(s) SUSPENSION
Route of administration OPHTHALMIC
Packaging size 10ml
ATC code S01BA
ATC description ANTIINFLAMMATORY AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2018-08-09
Actual start date
Estimated end date 2018-08-31
Actual end date 2018-08-23
Shortage status Resolved
Updated date 2018-08-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1400 N GOODMAN STREET
ROCHESTER, NEW YORK
UNITED STATES 14609
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2018-08-24 French Compare
v11 2018-08-24 English Compare
v10 2018-08-10 French Compare
v9 2018-08-10 English Compare
v8 2018-08-08 English Compare
v7 2018-08-03 French Compare
v6 2018-08-03 English Compare
v5 2018-08-03 English Compare
v4 2018-07-27 French Compare
v3 2018-07-27 English Compare
v2 2018-07-13 French Compare
v1 2018-07-13 English Compare

Showing 1 to 12 of 12